Loading...
XSHG
603301
Market cap2.61bUSD
Dec 05, Last price  
69.20CNY
1D
-5.99%
1Q
174.28%
IPO
82.11%
Name

ZHENDE MEDICAL CO LTD

Chart & Performance

D1W1MN
XSHG:603301 chart
P/E
47.85
P/S
4.32
EPS
1.45
Div Yield, %
0.72%
Shrs. gr., 5y
6.27%
Rev. gr., 5y
17.95%
Revenues
4.26b
+3.32%
986,914,9901,021,012,4171,034,899,3121,306,442,5401,428,856,6841,867,727,91510,398,545,6385,091,572,4476,137,634,4314,127,044,0554,263,886,317
Net income
385m
+94.14%
21,774,56079,059,48282,841,569121,769,114130,203,577156,890,0612,549,453,200595,861,926679,878,142198,399,010385,170,721
CFO
461m
+2.00%
83,626,714142,699,376138,574,134182,343,95720,245,774197,762,7363,120,839,894817,629,3181,246,045,055452,107,162461,142,986
Dividend
Jul 03, 20240.5 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Zhende Medical Co., Ltd. engages in the research and development, production, and sale of medical care and protective equipment. It offers medical wound dressing products, sensory control protection products, pressure therapy and immobilization products, and stoma and chronic wounds, and home care products. The company sells its products approximately in 73 countries, including Europe, the United States, and China. The company was founded in 1994 and is based in Shaoxing, China.
IPO date
Apr 12, 2018
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT